. A randomized, placebo-controlled trial of latrepirdine in huntington disease. Arch Neurol. 2010 Feb;67(2):154-60. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

News

  1. Dimebon for HD—A Hint of Cognitive Benefit?